PUBLIC CONTRACT · 2026

Aquisição de Miricizumab 300 mg Concentrado para solução para perfusão, Miricizumab 100 mg/ml + 200 mg/2ml Sol inj Caneta SC e Miricizumab 200 mg/2 ml Sol inj Caneta 2 ml SC.

Contract value: €77,061.21
Signed on: 11 October 2026
Procedure: Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 15767320

PUBLISHED SUBJECT

WHO CONTRACTED

Parties involved

Contracting body: Unidade Local Saúde de Braga, E.P.E.
Awardee: LILLY PORTUGAL - PRODUTOS FARMACEUTICOS
Place of performance: Portugal, Braga, Braga
NUTS region: PT112 - Cávado

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: LILLY PORTUGAL - PRODUTOS FARMACEUTICOS · Tax ID 500165602

HOW MUCH AND WHEN

Values and timeline

Contract price: €77,061.21
Procedure base price: €77,061.21
Total effective price: Not reported on Portal BASE
Publication date: 14 October 2026
Award date: 16 September 2026
Signing date: 11 October 2026
Performance period: 120 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Direct award, general (Ajuste Direto Regime Geral)
Award criterion: Monofator
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement: Not stated
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 11558430

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts